Online Exclusives

Online Exclusives

FDA Announces New Plans to Regulate Tobacco and Nicotine Products

The U.S. Food and Drug Administration (FDA) has announced a multi-year, comprehensive plan for tobacco and nicotine regulation that aims to reduce tobacco-related disease...

FDA Approves Ibrutinib as First Therapy for Chronic-Graft-Versus Host Disease

The U.S. Food and Drug Administration (FDA) approved ibrutinib – a Bruton tyrosine kinase inhibitor that treats mantle cell lymphoma, chronic lymphocytic leukemia, and...

Senate Voted to Continue FDA User Fees and Passed “Right to Try” Bill

The U.S. Senate voted 94-1 to approve two pieces of health-care legislation: one that continues the U.S. Food and Drug Administration’s (FDA) authority to...

President Declares State of Emergency After Urged by Federal Opioid Commission

On August 10, President Trump declared the opioid crisis a national emergency in response to a report from the Commission on Combating Drug Addiction...

Measuring DNA-TGN May Help Determine Whether Patients With ALL Receive Sufficient Maintenance Therapy Intensity

Author’s Perspective Study co-author Kjeld Schmiegelow, MD: “Maintenance-treatment intensity may be difficult to monitor by blood counts due to their large intra-individual variations. DNA-TGN seems...

FDA Approves Combination Daunorubicin and Cytarabine for High-Risk AML

The U.S. Food and Drug Administration approved CPX-351, a fixed combination of cytarabine and daunorubicin, for the treatment of adults with newly diagnosed therapy-related...

Venetoclax Gets Breakthrough-Therapy Designation for AML

The U.S. Food and Drug Administration granted breakthrough-therapy designation to the BCL2 inhibitor venetoclax, in combination with cytarabine, for the treatment of older patients...

Researchers Carry Out First Gene Editing of Embryos in the United States

A team of researchers at Oregon Health and Science University (OHSU) successfully used gene-editing technology to correct defective genes in a human embryo. This...

Pharma Company Settles Lawsuit Over Inappropriate Marketing

The pharmaceutical company Celgene has settled a lawsuit with a former sales representative, in which she alleged that the company marketed two of its...

Senate Votes Against Sought-After Health-Care Repeal Bill

In a 49-51 vote on July 27, the U.S. Senate voted against the Health Care Freedom Act, also called the “skinny repeal” bill. Many Republican...
Advertisement

Current Issue

August 2017, Volume 3, Issue 10

This issue features a comparison between American and European drug approval processes, a conversation with a lymphoma doctor running for Congress, highlights from recent hematology/oncology meetings, and more.